These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3128906)

  • 1. Feline aortic thromboemboli and the potential utility of thrombolytic therapy with tissue plasminogen activator.
    Pion PD
    Vet Clin North Am Small Anim Pract; 1988 Jan; 18(1):79-86. PubMed ID: 3128906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feline aortic thromboemboli: t-PA thrombolysis followed by aspirin therapy and rethrombosis.
    Pion PD
    Vet Clin North Am Small Anim Pract; 1988 Jan; 18(1):262-3. PubMed ID: 3128905
    [No Abstract]   [Full Text] [Related]  

  • 3. Feline aortic thromboemboli.
    Pion PD
    Vet Clin North Am Small Anim Pract; 1988 Jan; 18(1):260-2. PubMed ID: 3128904
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombolysis with tissue plasminogen activator (TPA) in feline acute aortic thromboembolism: a retrospective study of 16 cases.
    Guillaumin J; Gibson RM; Goy-Thollot I; Bonagura JD
    J Feline Med Surg; 2019 Apr; 21(4):340-346. PubMed ID: 29807505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clopidogrel on tissue-plasminogen activator-induced in vitro thrombolysis of feline whole blood thrombi.
    Hogan DF; Ward MP
    Am J Vet Res; 2004 Jun; 65(6):715-9. PubMed ID: 15198208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of tissue plasminogen activator in 11 cats with arterial thromboembolism.
    Welch KM; Rozanski EA; Freeman LM; Rush JE
    J Feline Med Surg; 2010 Feb; 12(2):122-8. PubMed ID: 19740689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of tissue plasminogen activator for systemic thrombolysis in dogs and cats.
    Diaz DM; Scansen BA; Lake Z; Shropshire S; Orton EC; Guillaumin J
    J Vet Cardiol; 2022 Jun; 41():154-164. PubMed ID: 35364502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of new thrombolytic substances].
    Zeymer U; Neuhaus KL
    Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local intra-arterial administration of urokinase in the treatment of a feline distal aortic thromboembolism.
    Koyama H; Matsumoto H; Fukushima RU; Hirose H
    J Vet Med Sci; 2010 Sep; 72(9):1209-11. PubMed ID: 20379085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral lysis of aortic saddle thrombus with early tissue plasminogen activator (BLASTT): a prospective, randomized, placebo-controlled study in feline acute aortic thromboembolism.
    Guillaumin J; DeFrancesco TC; Scansen BA; Quinn R; Whelan M; Hanel R; Goy-Thollot I; Bublot I; Robertson JB; Bonagura JD
    J Feline Med Surg; 2022 Dec; 24(12):e535-e545. PubMed ID: 36350753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptokinase treatment of cats with experimentally induced aortic thrombosis.
    Killingsworth CR; Eyster GE; Adams T; Bartlett PC; Bell TG
    Am J Vet Res; 1986 Jun; 47(6):1351-9. PubMed ID: 3729139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial thromboembolism in cats].
    Dirven MJ; Cornelissen JM
    Tijdschr Diergeneeskd; 2009 Dec; 134(23):974-80. PubMed ID: 20069976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of rheolytic thrombectomy in the treatment of feline distal aortic thromboembolism.
    Reimer SB; Kittleson MD; Kyles AE
    J Vet Intern Med; 2006; 20(2):290-6. PubMed ID: 16594585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for or against efficacy of beta-blockers and aspirin for management of feline cardiomyopathies.
    Fox PR
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):1011-22. PubMed ID: 1683044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic effects of tissue-type and urokinase-type plasminogen activators in rabbits with experimental pulmonary thromboembolization.
    Rahman F
    Fukuoka Igaku Zasshi; 1990 Sep; 81(9):303-12. PubMed ID: 2125971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
    Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
    N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current issues concerning thrombolytic therapy for acute myocardial infarction.
    Hennekens CH; O'Donnell CJ; Ridker PM; Marder VJ
    J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):18S-22S. PubMed ID: 7775709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoeconomic aspects of treatment of acute myocardial infarction with thrombolytic agents.
    Woo KS; White HD
    Pharmacoeconomics; 1993 Mar; 3(3):192-204. PubMed ID: 10172049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.